China Shineway Pharmaceutical Group Ltd. (SHINEWAY PHARM, 2877.HK) is listed on HKEX. The latest available quote update was captured at 2026-03-26 10:40:17.0.
Quote Snapshot
- Last Price: 8.640 HKD
- Day Change: -0.160 (-1.82%)
- Open: 8.700 HKD
- High: 8.800 HKD
- Low: 8.600 HKD
- Previous Close: 8.800 HKD
- Volume: 1.44 M
- Market Cap: 7.14 B
- P/E Ratio: 7.35
- Dividend Yield: 5.84%
- Board Lot: 1,000
- ISIN: KYG2110P1000
- Industry: Healthcare - Pharmaceuticals & Biotechnology
Company Overview
China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.
Risk & Return Metrics
Based on 490 trading days of close price data (daily returns, annualized using 252 trading days).
| Metric | Daily | Annualized |
|---|---|---|
| Expected Return | -0.0034% | -0.86% |
| Risk (Std Dev) | 2.0035% | 31.80% |
| Metric | Value |
|---|---|
| First Price (HKD) | 9.870 |
| Last Price (HKD) | 8.800 |
| Total Return | -10.84% |